The Journal for ImmunoTherapy of CancerĀ (JITC) is an open access, peer-reviewed journal that aims to enrich communication and advance scientific understanding in the rapidly evolving fields of tumor immunology and cancer immunotherapy. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

Publisher
BMJ
Website
https://jitc.bmj.com/

Some content from Wikipedia, licensed under CC BY-SA

Sorry, no news articles match your request. Your search criteria may be too narrow.